Drug Profile
Beclometasone monodose nebuliser solution - Chiesi
Alternative Names: BDP UDV; Clenil ALatest Information Update: 19 Dec 2021
Price :
$50
*
At a glance
- Originator Chiesi Farmaceutici
- Class Anti-inflammatories; Antiallergics; Antiasthmatics; Chlorinated steroids; Corticosteroids; Pregnadienetriols; Small molecules; Vascular disorder therapies
- Mechanism of Action Immunosuppressants; Steroid receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Asthma
- Discontinued Rhinosinusitis
Most Recent Events
- 28 Sep 2021 Discontinued - Phase-III for Rhinosinusitis (Adjunctive treatment) in Italy (Inhalation) (Chiesi Farmaceutici's website, September 2021)
- 13 Jul 2020 Chiesi Farmaceutici and Bayer entered into a co-promotion agreement for Clenil® for Chronic respiratory diseases in China
- 02 Sep 2016 No development reported - Phase-III for Rhinosinusitis (Adjunctive treatment) in Italy (Inhalation)